Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside

Bempedoic acid is a first-in-class, oral, inhibitor of cholesterol biosynthesis that is approved for use in patients with atherosclerotic cardiovascular disease (ASCVD) and for primary prevention in individuals with heterozygous familial hypercholesterolemia (HeFH) by the United States Food and Drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwala, Anandita, Quispe, Renato, Goldberg, Anne C, Michos, Erin D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121276/
https://www.ncbi.nlm.nih.gov/pubmed/34007155
http://dx.doi.org/10.2147/DDDT.S251865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121276/
https://www.ncbi.nlm.nih.gov/pubmed/34007155
http://dx.doi.org/10.2147/DDDT.S251865

Ejemplares similares